FDA Adverse Event Injury Summary report: N

TELIGEN

MDR report key: 4884358 · Received July 1, 2015

Report

Report Number
2124215-2015-07103
Event Type
Injury
Date Received
July 1, 2015
Date of Event
May 20, 2015
Report Date
June 5, 2015
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FL
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE PRODUCT IS EXPECTED TO BE RETURNED FOR ANALYSIS. THIS REPORT WILL BE UPDATED UPON RETURN AND COMPLETION OF ANALYSIS.

Additional Manufacturer Narrative · 1

(B)(4). UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, VISUAL INSPECTION OF THE ICD IDENTIFIED NO ANOMALIES. REVIEW OF DEVICE MEMORY FOUND A SHORTED LEAD FAULT (FAULT CODE 1005) WAS RECORDED. AN X-RAY OF THE DEVICE REVEALED THAT THE INTERNAL HIGH VOLTAGE FUSE WAS DAMAGED (I.E., NO LONGER INTACT). THE DAMAGE TO THE FUSE MOST LIKELY OCCURRED DURING DELIVERY OF THE SHOCK THAT RESULTED IN THE SHORTED SHOCK LEAD FAULT. THE DAMAGE TO THE HIGH VOLTAGE FUSE PREVENTED ANY SUBSEQUENT CHARGING OF THE HIGH VOLTAGE CAPACITORS AND DELIVERY OF SHOCK THERAPY.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT IMPLANTED WITH THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) AND RIGHT VENTRICULAR (RV) LEAD COMPLAINED OF CHEST PAIN. UPON INTERROGATION OF THE ICD WITH A PROGRAMMER, A SHOCK LEAD SHORTED MESSAGE WAS OBSERVED. REVIEW OF STORED DEVICE MEMORY REVEALED LOW OUT OF RANGE SHOCK IMPEDANCE MEASUREMENTS LESS THAN 20 OHMS DURING DELIVERY OF APPROPRIATE ANTI-TACHYCARDIA PACING (ATP) AND SHOCK THERAPY. AN INVASIVE PROCEDURE WAS PERFORMED. THE DEVICE WAS EXPLANTED AND REPLACED AND THE LEAD WAS SURGICALLY ABANDONED AND REPLACED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
426222 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E110

Patients

Seq Age Sex Outcome Treatment
1 48 YR Hospitalization| L| R 0175| E110| 4135